OR WAIT null SECS
December 20, 2021
The agency recommended granting conditional marketing authorization for use of Nuvaxovid in people 18 years of age and older.
December 17, 2021
FDA has become embroiled in the debate over access to “chemical” or “medication” abortions through the prescribing and distribution of the abortifacient mifepristone.
December 16, 2021
General agreement that FDA needs a confirmed commissioner may speed Califf’s appointment.
December 15, 2021
GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 07, 2021
President Joe Biden highlighted how current proposals for curbing outlays on pharmaceuticals will help protect patients’ health and save the government billions.
December 03, 2021
This collaboration aims to better understand Alzheimer’s and Parkinson’s disease and increase drug discovery and development success rates.
December 02, 2021
The new General Chapter “Nitrosamines Impurities” by USP became official on Dec. 2, 2021, in the United States Pharmacopeia—National Formulary.
November 22, 2021
Speed to market, flexibility, and digitalization are important topics in biopharmaceutical manufacturing.
November 19, 2021
FDA has amended its EUA for Pfizer-BioNTech’s and Moderna’s COVID-19 booster to include all individuals aged 18 or older.